Survey Reinforces the Effectiveness of Anti-TNF-Alpha to Treat Pediatric CD

Survey Reinforces the Effectiveness of Anti-TNF-Alpha to Treat Pediatric CD
Anti-tumor necrosis factor-α (TNF-Alpha) has been further established as an effective treatment for children who suffer from Crohn’s disease (CD), as evaluated by a recent multi-institute survey. The results were published in the journal Pediatrics, compiling the collection of data from the ImproveCareNow (ICN) program, led by Christopher B. Forrest, MD, PhD, from the Department of Pediatrics at the Children’s Hospital

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *